Jacky Van Dun

805 total citations
27 papers, 633 citations indexed

About

Jacky Van Dun is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jacky Van Dun has authored 27 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jacky Van Dun's work include Receptor Mechanisms and Signaling (9 papers), Click Chemistry and Applications (5 papers) and Estrogen and related hormone effects (5 papers). Jacky Van Dun is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Click Chemistry and Applications (5 papers) and Estrogen and related hormone effects (5 papers). Jacky Van Dun collaborates with scholars based in Belgium, United States and France. Jacky Van Dun's co-authors include Walter Wouters, Pierre M. Laduron, R. De Coster, Marc Venet, Michel Janicot, W Cools, Eddy Freyne, M C Coene, D. Beerens and Wim Floren and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and FEBS Letters.

In The Last Decade

Jacky Van Dun

27 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacky Van Dun Belgium 14 379 176 144 97 72 27 633
Antonio Caldarelli Italy 13 221 0.6× 78 0.4× 226 1.6× 72 0.7× 40 0.6× 21 590
Paul E. Driedger United States 11 674 1.8× 67 0.4× 107 0.7× 158 1.6× 72 1.0× 14 944
Walter Wouters Belgium 21 651 1.7× 551 3.1× 182 1.3× 143 1.5× 85 1.2× 52 1.2k
Jacques Gilbert France 12 147 0.4× 154 0.9× 147 1.0× 29 0.3× 29 0.4× 17 420
James H. Williams Australia 20 523 1.4× 86 0.5× 358 2.5× 55 0.6× 44 0.6× 41 933
R. Van Ginckel Belgium 12 199 0.5× 209 1.2× 57 0.4× 55 0.6× 7 0.1× 23 418
Robert A. Hickie Canada 15 567 1.5× 59 0.3× 94 0.7× 112 1.2× 47 0.7× 29 845
John S. Schweppe United States 17 579 1.5× 130 0.7× 29 0.2× 78 0.8× 46 0.6× 40 852
L. McLean United States 10 539 1.4× 41 0.2× 56 0.4× 63 0.6× 82 1.1× 13 805

Countries citing papers authored by Jacky Van Dun

Since Specialization
Citations

This map shows the geographic impact of Jacky Van Dun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacky Van Dun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacky Van Dun more than expected).

Fields of papers citing papers by Jacky Van Dun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacky Van Dun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacky Van Dun. The network helps show where Jacky Van Dun may publish in the future.

Co-authorship network of co-authors of Jacky Van Dun

This figure shows the co-authorship network connecting the top 25 collaborators of Jacky Van Dun. A scholar is included among the top collaborators of Jacky Van Dun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacky Van Dun. Jacky Van Dun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arts, Janine, Patrick Angibaud, Wim Floren, et al.. (2007). R306465 is a novel potent inhibitor of class I histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies. British Journal of Cancer. 97(10). 1344–1353. 77 indexed citations
2.
Angibaud, Patrick, Laurence Mévellec, Christophe Meyer, et al.. (2007). Impact on farnesyltransferase inhibition of 4-chlorophenyl moiety replacement in the Zarnestra® series. European Journal of Medicinal Chemistry. 42(5). 702–714. 7 indexed citations
3.
Dun, Jacky Van, Thierry Grand‐Perret, Stefanie De Schepper, et al.. (2006). Effect of an hdm-2 antagonist peptide inhibitor on cell cycle progression in p53-deficient H1299 human lung carcinoma cells. Oncogene. 25(50). 6672–6677. 21 indexed citations
4.
Schepper, Stefanie De, Wim Floren, Peter King, et al.. (2006). Real-time gene expression analysis in human xenografts for evaluation of histone deacetylase inhibitors. Molecular Cancer Therapeutics. 5(9). 2317–2323. 5 indexed citations
5.
Straetemans, Roel, Timothy E. O’Brien, Luc Wouters, et al.. (2005). Design and Analysis of Drug Combination Experiments. Biometrical Journal. 47(3). 299–308. 61 indexed citations
6.
7.
Angibaud, Patrick, Ashis Saha, David W. End, et al.. (2003). 4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™. Bioorganic & Medicinal Chemistry Letters. 13(24). 4361–4364. 13 indexed citations
8.
Angibaud, Patrick, Ann Devine, David W. End, et al.. (2003). 5-Imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(9). 1543–1547. 27 indexed citations
9.
Angibaud, Patrick, David W. End, Eddy Freyne, et al.. (2003). Substituted azoloquinolines and -quinazolines as new potent farnesyl protein transferase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(24). 4365–4369. 19 indexed citations
10.
Mocek, Ursula, et al.. (2003). R176502, a New Bafilolide Metabolite with Potent Antiproliferative Activity from a Novel Micromonospora Species. The Journal of Antibiotics. 56(11). 909–916. 14 indexed citations
11.
Ginckel, R. Van, Bieneke Janssen, Wim Floren, et al.. (2002). Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. British Journal of Cancer. 86(4). 605–611. 75 indexed citations
12.
Verhoeven, A. J., Jacky Van Dun, W Cools, et al.. (1997). Induction of the oxidative catabolism of retinoic acid in MCF-7 cells. British Journal of Cancer. 75(8). 1098–1104. 15 indexed citations
13.
Wouters, Walter, R. De Coster, Jacky Van Dun, et al.. (1990). Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo. The Journal of Steroid Biochemistry and Molecular Biology. 37(6). 1049–1054. 30 indexed citations
14.
Wouters, Walter, R. De Coster, Jacky Van Dun, et al.. (1989). R 76713, a new specific non-steroidal aromatase inhibitor. Journal of Steroid Biochemistry. 32(6). 781–788. 76 indexed citations
15.
Wouters, Walter, et al.. (1988). Aromatase inhibition by the antifungal ketoconazole. Journal of Steroid Biochemistry. 30(1-6). 387–389. 18 indexed citations
16.
Wouters, Walter, Jacky Van Dun, & Pierre M. Laduron. (1986). 7-Amino-8-[125I]-ketanserin ([125I]AMIK), a highly sensitive, serotonin-S2 receptor ligand. Biochemical Pharmacology. 35(19). 3199–3202. 13 indexed citations
17.
Laduron, Pierre M., Josée E. Leysen, W Gommeren, et al.. (1986). Impact of Janssen drugs for the identification of brain receptors. Drug Development Research. 8(1-4). 15–26. 1 indexed citations
18.
Wouters, Walter, Jacky Van Dun, J.E. Leysen, & Pierre M. Laduron. (1985). Photoaffinity probes for serotonin and histamine receptors. Synthesis and characterization of two azide analogues of ketanserin.. Journal of Biological Chemistry. 260(14). 8423–8429. 21 indexed citations
19.
Wouters, Walter, Jacky Van Dun, & Pierre M. Laduron. (1984). Characterization of cholate-solubilized dopamine receptors from human, dog and rat brain. Biochemical Pharmacology. 33(24). 4039–4044. 12 indexed citations
20.
Wouters, Walter, Jacky Van Dun, & Pierre M. Laduron. (1984). Photoaffinity labelling of dopamine receptors. European Journal of Biochemistry. 145(2). 273–278. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Caldarelli Breakdown of academic impact, for papers by Paul E. Driedger Breakdown of academic impact, for papers by Walter Wouters Breakdown of academic impact, for papers by Jacques Gilbert Breakdown of academic impact, for papers by James H. Williams Breakdown of academic impact, for papers by R. Van Ginckel Breakdown of academic impact, for papers by Robert A. Hickie Breakdown of academic impact, for papers by John S. Schweppe Breakdown of academic impact, for papers by L. McLean
Rankless by CCL
2026